Michael Krämer

7.4k total citations
103 papers, 2.9k citations indexed

About

Michael Krämer is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Michael Krämer has authored 103 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Hematology, 25 papers in Molecular Biology and 25 papers in Oncology. Recurrent topics in Michael Krämer's work include Acute Myeloid Leukemia Research (48 papers), Hematopoietic Stem Cell Transplantation (19 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers). Michael Krämer is often cited by papers focused on Acute Myeloid Leukemia Research (48 papers), Hematopoietic Stem Cell Transplantation (19 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers). Michael Krämer collaborates with scholars based in Germany, United States and United Kingdom. Michael Krämer's co-authors include Gerhard Ehninger, Martin Bornhäuser, Christoph Röllig, Christian Thiede, Markus Schaich, Malte von Bonin, Frank Kroschinsky, Johannes Schetelig, Friedrich Stölzel and Martin Wermke and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Michael Krämer

99 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Krämer Germany 31 1.4k 774 693 534 375 103 2.9k
Tobias Herold Germany 25 859 0.6× 448 0.6× 926 1.3× 254 0.5× 230 0.6× 121 2.9k
Markus Metzler Germany 31 787 0.5× 283 0.4× 718 1.0× 428 0.8× 570 1.5× 130 2.8k
C. Michel Zwaan Netherlands 38 2.1k 1.4× 608 0.8× 1.7k 2.4× 401 0.8× 1.3k 3.4× 152 3.9k
Biljana Horn United States 29 735 0.5× 305 0.4× 378 0.5× 490 0.9× 260 0.7× 84 2.0k
Moshe Mittelman Israel 30 2.1k 1.5× 450 0.6× 620 0.9× 1.0k 1.9× 216 0.6× 186 3.3k
Ephraim P. Hochberg United States 42 1.2k 0.8× 1.9k 2.4× 619 0.9× 1.2k 2.3× 569 1.5× 148 5.2k
Kim Vettenranta Finland 31 1.0k 0.7× 654 0.8× 571 0.8× 249 0.5× 1.6k 4.1× 167 3.4k
Faiz Anwer United States 23 963 0.7× 1.1k 1.5× 782 1.1× 342 0.6× 171 0.5× 328 2.5k
David Gómez‐Almaguer Mexico 29 1.9k 1.3× 579 0.7× 327 0.5× 700 1.3× 741 2.0× 335 3.0k
Caroline Elie France 35 619 0.4× 256 0.3× 824 1.2× 430 0.8× 214 0.6× 101 3.4k

Countries citing papers authored by Michael Krämer

Since Specialization
Citations

This map shows the geographic impact of Michael Krämer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Krämer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Krämer more than expected).

Fields of papers citing papers by Michael Krämer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Krämer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Krämer. The network helps show where Michael Krämer may publish in the future.

Co-authorship network of co-authors of Michael Krämer

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Krämer. A scholar is included among the top collaborators of Michael Krämer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Krämer. Michael Krämer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Schlenk, Richard F., Jan Moritz Middeke, Stefan W. Krause, et al.. (2024). Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AML. Blood Advances. 9(2). 375–385. 1 indexed citations
3.
Krämer, Michael, Christian Thiede, Stefan W. Krause, et al.. (2022). Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemia. Leukemia. 36(9). 2208–2217. 12 indexed citations
4.
Eckardt, Jan‐Niklas, Michael Krämer, Katja Sockel, et al.. (2022). Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears. BMC Cancer. 22(1). 201–201. 41 indexed citations
5.
Eckardt, Jan‐Niklas, Jan Moritz Middeke, Michael Krämer, et al.. (2021). Deep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears. Leukemia. 36(1). 111–118. 60 indexed citations
6.
Hölig, Kristina, Helmuth Schmidt, Gero Hütter, et al.. (2020). Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial. Bone Marrow Transplantation. 56(3). 635–645. 11 indexed citations
7.
Krämer, Michael, Heidi Altmann, Lisa Wagenführ, et al.. (2020). Lysyl oxidase expression is associated with inferior outcome and Extramedullary disease of acute myeloid leukemia. Biomarker Research. 8(1). 20–20. 8 indexed citations
8.
Stölzel, Friedrich, Steffen Löck, Stefani Parmentier, et al.. (2019). The prevalence of extramedullary acute myeloid leukemia detected by 18FDG-PET/CT: final results from the prospective PETAML trial. Haematologica. 105(6). 1552–1558. 34 indexed citations
9.
Teipel, Raphael, Uta Oelschlägel, Michael Krämer, et al.. (2018). Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts from Healthy Stem Cell Donors Mobilized with Either Granulocyte Colony-Stimulating Factor (G-CSF) Alone or G-CSF and Plerixafor. Biology of Blood and Marrow Transplantation. 24(11). 2171–2177. 24 indexed citations
10.
11.
Schubert, Barbara, Michael Krämer, Felicitas Lenz, et al.. (2017). Benefits and risks of a percutaneous endoscopic gastrostomy (PEG) for decompression in patients with malignant gastrointestinal obstruction. Supportive Care in Cancer. 25(9). 2849–2856. 19 indexed citations
12.
Venables, Noah C., James R. Yancey, Michael Krämer, et al.. (2017). Psychoneurometric assessment of dispositional liabilities for suicidal behavior: phenotypic and etiological associations. Psychological Medicine. 48(3). 463–472. 9 indexed citations
13.
Schuler, Markus K., Leopold Hentschel, Michael Krämer, et al.. (2016). Impact of Different Exercise Programs on Severe Fatigue in Patients Undergoing Anticancer Treatment—A Randomized Controlled Trial. Journal of Pain and Symptom Management. 53(1). 57–66. 32 indexed citations
14.
Ehninger, Armin, Michael Krämer, Christoph Röllig, et al.. (2014). Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia. Blood Cancer Journal. 4(6). e218–e218. 260 indexed citations
15.
Röllig, Christoph, Matthias Hänel, Michael Krämer, et al.. (2014). Two cycles of risk-adapted consolidation therapy in patients with acute promyelocytic leukemia. Results from the SAL-AIDA2000 trial. Annals of Hematology. 94(4). 557–563. 5 indexed citations
16.
Bochtler, Tilmann, Friedrich Stölzel, Christoph E. Heilig, et al.. (2013). Clonal Heterogeneity As Detected by Metaphase Karyotyping Is an Indicator of Poor Prognosis in Acute Myeloid Leukemia. Journal of Clinical Oncology. 31(31). 3898–3905. 51 indexed citations
17.
Stoehlmacher-Williams, Jan, Salah‐Eddin Al‐Batran, N Heussen, et al.. (2013). Prognostic role of microRNA polymorphisms in advanced gastric cancer: a translational study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). Annals of Oncology. 24(10). 2581–2588. 36 indexed citations
18.
Cole, F. Sessions, John Barks, Robert Boyle, et al.. (2010). NIH consensus development conference: Inhaled nitric oxide therapy for premature infants.. PubMed. 27(5). 1–34. 19 indexed citations
19.
Stölzel, Friedrich, Markus Pfirrmann, Walter E. Aulitzky, et al.. (2010). Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trial. Leukemia. 25(3). 420–428. 21 indexed citations
20.
Berger, S A, et al.. (1993). Effect of surgical mask position on bacterial contamination of the operative field. Journal of Hospital Infection. 23(1). 51–54. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tobias Herold Breakdown of academic impact, for papers by Markus Metzler Breakdown of academic impact, for papers by C. Michel Zwaan Breakdown of academic impact, for papers by Biljana Horn Breakdown of academic impact, for papers by Moshe Mittelman Breakdown of academic impact, for papers by Ephraim P. Hochberg Breakdown of academic impact, for papers by Kim Vettenranta Breakdown of academic impact, for papers by Faiz Anwer Breakdown of academic impact, for papers by David Gómez‐Almaguer Breakdown of academic impact, for papers by Caroline Elie
Rankless by CCL
2026